nodes	percent_of_prediction	percent_of_DWPC	metapath
Raltitrexed—TYMS—prostate cancer	0.435	1	CbGaD
Raltitrexed—TYMS—Capecitabine—prostate cancer	0.319	1	CbGbCtD
Raltitrexed—FPGS—prostate gland—prostate cancer	0.00425	0.21	CbGeAlD
Raltitrexed—FPGS—seminal vesicle—prostate cancer	0.0036	0.177	CbGeAlD
Raltitrexed—FPGS—urethra—prostate cancer	0.00285	0.14	CbGeAlD
Raltitrexed—TYMS—prostate gland—prostate cancer	0.00279	0.138	CbGeAlD
Raltitrexed—FPGS—testis—prostate cancer	0.00187	0.0924	CbGeAlD
Raltitrexed—TYMS—bone marrow—prostate cancer	0.00144	0.0709	CbGeAlD
Raltitrexed—FPGS—lymph node—prostate cancer	0.00136	0.067	CbGeAlD
Raltitrexed—TYMS—Docetaxel—Cabazitaxel—prostate cancer	0.00132	0.349	CbGdCrCtD
Raltitrexed—TYMS—testis—prostate cancer	0.00123	0.0606	CbGeAlD
Raltitrexed—TYMS—Paclitaxel—Cabazitaxel—prostate cancer	0.000914	0.241	CbGdCrCtD
Raltitrexed—TYMS—lymph node—prostate cancer	0.000891	0.0439	CbGeAlD
Raltitrexed—Methotrexate—AOX1—prostate cancer	0.000704	0.176	CrCbGaD
Raltitrexed—Pralatrexate—TYMS—prostate cancer	0.00067	0.167	CrCbGaD
Raltitrexed—Leucovorin—TYMS—prostate cancer	0.00067	0.167	CrCbGaD
Raltitrexed—Pemetrexed—TYMS—prostate cancer	0.000535	0.134	CrCbGaD
Raltitrexed—TYMS—Paclitaxel—Docetaxel—prostate cancer	0.00038	0.1	CbGdCrCtD
Raltitrexed—Tetrahydrofolic acid—MTHFR—prostate cancer	0.000343	0.0857	CrCbGaD
Raltitrexed—Folic Acid—MTHFR—prostate cancer	0.000343	0.0857	CrCbGaD
Raltitrexed—Methotrexate—TYMS—prostate cancer	0.000295	0.0737	CrCbGaD
Raltitrexed—TYMS—Podofilox—Etoposide—prostate cancer	0.000244	0.0642	CbGdCrCtD
Raltitrexed—TYMS—Levorphanol—Estrone—prostate cancer	0.000242	0.0636	CbGdCrCtD
Raltitrexed—Methotrexate—MTHFR—prostate cancer	0.000235	0.0586	CrCbGaD
Raltitrexed—Folic Acid—CYP2E1—prostate cancer	0.000209	0.0521	CrCbGaD
Raltitrexed—TYMS—Levorphanol—Estradiol—prostate cancer	0.000183	0.0482	CbGdCrCtD
Raltitrexed—Renal impairment—Epirubicin—prostate cancer	0.000131	0.000948	CcSEcCtD
Raltitrexed—Infection—Mitoxantrone—prostate cancer	0.000131	0.000944	CcSEcCtD
Raltitrexed—Neutropenia—Prednisone—prostate cancer	0.000129	0.000932	CcSEcCtD
Raltitrexed—Thrombocytopenia—Mitoxantrone—prostate cancer	0.000129	0.000931	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Estradiol—prostate cancer	0.000129	0.000929	CcSEcCtD
Raltitrexed—Nausea—Ethinyl Estradiol—prostate cancer	0.000129	0.000929	CcSEcCtD
Raltitrexed—Hepatic failure—Doxorubicin—prostate cancer	0.000129	0.000928	CcSEcCtD
Raltitrexed—Asthenia—Goserelin—prostate cancer	0.000128	0.000923	CcSEcCtD
Raltitrexed—Cardiac failure congestive—Doxorubicin—prostate cancer	0.000127	0.00092	CcSEcCtD
Raltitrexed—Hyperhidrosis—Mitoxantrone—prostate cancer	0.000127	0.000919	CcSEcCtD
Raltitrexed—Asthenia—Conjugated Estrogens—prostate cancer	0.000127	0.000915	CcSEcCtD
Raltitrexed—Pruritus—Goserelin—prostate cancer	0.000126	0.00091	CcSEcCtD
Raltitrexed—Anorexia—Mitoxantrone—prostate cancer	0.000126	0.000906	CcSEcCtD
Raltitrexed—Pruritus—Conjugated Estrogens—prostate cancer	0.000125	0.000902	CcSEcCtD
Raltitrexed—Weight decreased—Prednisone—prostate cancer	0.000125	0.000902	CcSEcCtD
Raltitrexed—Ill-defined disorder—Etoposide—prostate cancer	0.000125	0.000899	CcSEcCtD
Raltitrexed—Dyspepsia—Estradiol—prostate cancer	0.000124	0.000898	CcSEcCtD
Raltitrexed—Anaemia—Etoposide—prostate cancer	0.000124	0.000895	CcSEcCtD
Raltitrexed—Decreased appetite—Estradiol—prostate cancer	0.000123	0.000887	CcSEcCtD
Raltitrexed—Diarrhoea—Goserelin—prostate cancer	0.000122	0.000881	CcSEcCtD
Raltitrexed—Renal impairment—Doxorubicin—prostate cancer	0.000121	0.000877	CcSEcCtD
Raltitrexed—Malaise—Etoposide—prostate cancer	0.000121	0.000874	CcSEcCtD
Raltitrexed—TYMS—Danazol—Ethinyl Estradiol—prostate cancer	0.000121	0.0318	CbGdCrCtD
Raltitrexed—Constipation—Estradiol—prostate cancer	0.000121	0.000872	CcSEcCtD
Raltitrexed—Pain—Estradiol—prostate cancer	0.000121	0.000872	CcSEcCtD
Raltitrexed—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000121	0.000872	CcSEcCtD
Raltitrexed—Leukopenia—Etoposide—prostate cancer	0.00012	0.000867	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Mitoxantrone—prostate cancer	0.00012	0.000866	CcSEcCtD
Raltitrexed—Cough—Etoposide—prostate cancer	0.000117	0.000845	CcSEcCtD
Raltitrexed—Feeling abnormal—Estradiol—prostate cancer	0.000116	0.000841	CcSEcCtD
Raltitrexed—Dehydration—Epirubicin—prostate cancer	0.000116	0.000839	CcSEcCtD
Raltitrexed—Dyspepsia—Mitoxantrone—prostate cancer	0.000116	0.000837	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Estradiol—prostate cancer	0.000116	0.000834	CcSEcCtD
Raltitrexed—Decreased appetite—Mitoxantrone—prostate cancer	0.000114	0.000826	CcSEcCtD
Raltitrexed—Arrhythmia—Docetaxel—prostate cancer	0.000114	0.000826	CcSEcCtD
Raltitrexed—Vomiting—Goserelin—prostate cancer	0.000113	0.000818	CcSEcCtD
Raltitrexed—Alopecia—Docetaxel—prostate cancer	0.000113	0.000817	CcSEcCtD
Raltitrexed—Discomfort—Etoposide—prostate cancer	0.000113	0.000815	CcSEcCtD
Raltitrexed—Pain—Mitoxantrone—prostate cancer	0.000113	0.000813	CcSEcCtD
Raltitrexed—Constipation—Mitoxantrone—prostate cancer	0.000113	0.000813	CcSEcCtD
Raltitrexed—Rash—Goserelin—prostate cancer	0.000112	0.000811	CcSEcCtD
Raltitrexed—Dermatitis—Goserelin—prostate cancer	0.000112	0.000811	CcSEcCtD
Raltitrexed—Vomiting—Conjugated Estrogens—prostate cancer	0.000112	0.00081	CcSEcCtD
Raltitrexed—Abdominal pain—Estradiol—prostate cancer	0.000112	0.000806	CcSEcCtD
Raltitrexed—Body temperature increased—Estradiol—prostate cancer	0.000112	0.000806	CcSEcCtD
Raltitrexed—Headache—Goserelin—prostate cancer	0.000112	0.000806	CcSEcCtD
Raltitrexed—Rash—Conjugated Estrogens—prostate cancer	0.000111	0.000804	CcSEcCtD
Raltitrexed—Dermatitis—Conjugated Estrogens—prostate cancer	0.000111	0.000803	CcSEcCtD
Raltitrexed—Arrhythmia—Capecitabine—prostate cancer	0.000111	0.0008	CcSEcCtD
Raltitrexed—Headache—Conjugated Estrogens—prostate cancer	0.000111	0.000799	CcSEcCtD
Raltitrexed—Alopecia—Capecitabine—prostate cancer	0.00011	0.000791	CcSEcCtD
Raltitrexed—Dysgeusia—Docetaxel—prostate cancer	0.000109	0.000788	CcSEcCtD
Raltitrexed—Infection—Etoposide—prostate cancer	0.000109	0.000786	CcSEcCtD
Raltitrexed—Feeling abnormal—Mitoxantrone—prostate cancer	0.000109	0.000783	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.000108	0.000777	CcSEcCtD
Raltitrexed—Dehydration—Doxorubicin—prostate cancer	0.000108	0.000776	CcSEcCtD
Raltitrexed—Thrombocytopenia—Etoposide—prostate cancer	0.000107	0.000774	CcSEcCtD
Raltitrexed—Nausea—Goserelin—prostate cancer	0.000106	0.000764	CcSEcCtD
Raltitrexed—Hyperhidrosis—Etoposide—prostate cancer	0.000106	0.000764	CcSEcCtD
Raltitrexed—Dysgeusia—Capecitabine—prostate cancer	0.000106	0.000763	CcSEcCtD
Raltitrexed—Nausea—Conjugated Estrogens—prostate cancer	0.000105	0.000757	CcSEcCtD
Raltitrexed—Anorexia—Etoposide—prostate cancer	0.000104	0.000754	CcSEcCtD
Raltitrexed—Body temperature increased—Mitoxantrone—prostate cancer	0.000104	0.000751	CcSEcCtD
Raltitrexed—Abdominal pain—Mitoxantrone—prostate cancer	0.000104	0.000751	CcSEcCtD
Raltitrexed—Anaemia—Docetaxel—prostate cancer	0.000103	0.000744	CcSEcCtD
Raltitrexed—Asthenia—Estradiol—prostate cancer	0.000101	0.000732	CcSEcCtD
Raltitrexed—Neutropenia—Epirubicin—prostate cancer	0.000101	0.000729	CcSEcCtD
Raltitrexed—Ill-defined disorder—Capecitabine—prostate cancer	0.0001	0.000723	CcSEcCtD
Raltitrexed—Pruritus—Estradiol—prostate cancer	0.0001	0.000722	CcSEcCtD
Raltitrexed—Leukopenia—Docetaxel—prostate cancer	9.98e-05	0.000721	CcSEcCtD
Raltitrexed—Anaemia—Capecitabine—prostate cancer	9.98e-05	0.00072	CcSEcCtD
Raltitrexed—Arrhythmia—Prednisone—prostate cancer	9.87e-05	0.000713	CcSEcCtD
Raltitrexed—Weight decreased—Epirubicin—prostate cancer	9.77e-05	0.000705	CcSEcCtD
Raltitrexed—Alopecia—Prednisone—prostate cancer	9.76e-05	0.000705	CcSEcCtD
Raltitrexed—Malaise—Capecitabine—prostate cancer	9.74e-05	0.000703	CcSEcCtD
Raltitrexed—Cough—Docetaxel—prostate cancer	9.73e-05	0.000703	CcSEcCtD
Raltitrexed—Diarrhoea—Estradiol—prostate cancer	9.67e-05	0.000698	CcSEcCtD
Raltitrexed—Leukopenia—Capecitabine—prostate cancer	9.67e-05	0.000698	CcSEcCtD
Raltitrexed—Decreased appetite—Etoposide—prostate cancer	9.52e-05	0.000687	CcSEcCtD
Raltitrexed—Arthralgia—Docetaxel—prostate cancer	9.5e-05	0.000685	CcSEcCtD
Raltitrexed—Renal failure—Epirubicin—prostate cancer	9.46e-05	0.000683	CcSEcCtD
Raltitrexed—Asthenia—Mitoxantrone—prostate cancer	9.45e-05	0.000682	CcSEcCtD
Raltitrexed—Cough—Capecitabine—prostate cancer	9.42e-05	0.00068	CcSEcCtD
Raltitrexed—Stomatitis—Epirubicin—prostate cancer	9.38e-05	0.000677	CcSEcCtD
Raltitrexed—Constipation—Etoposide—prostate cancer	9.37e-05	0.000676	CcSEcCtD
Raltitrexed—Pain—Etoposide—prostate cancer	9.37e-05	0.000676	CcSEcCtD
Raltitrexed—Conjunctivitis—Epirubicin—prostate cancer	9.36e-05	0.000675	CcSEcCtD
Raltitrexed—Neutropenia—Doxorubicin—prostate cancer	9.34e-05	0.000674	CcSEcCtD
Raltitrexed—Sweating—Epirubicin—prostate cancer	9.23e-05	0.000666	CcSEcCtD
Raltitrexed—Arthralgia—Capecitabine—prostate cancer	9.19e-05	0.000664	CcSEcCtD
Raltitrexed—Oedema—Docetaxel—prostate cancer	9.1e-05	0.000657	CcSEcCtD
Raltitrexed—Discomfort—Capecitabine—prostate cancer	9.08e-05	0.000656	CcSEcCtD
Raltitrexed—Infection—Docetaxel—prostate cancer	9.04e-05	0.000653	CcSEcCtD
Raltitrexed—Weight decreased—Doxorubicin—prostate cancer	9.04e-05	0.000652	CcSEcCtD
Raltitrexed—Feeling abnormal—Etoposide—prostate cancer	9.03e-05	0.000652	CcSEcCtD
Raltitrexed—Diarrhoea—Mitoxantrone—prostate cancer	9.01e-05	0.00065	CcSEcCtD
Raltitrexed—Vomiting—Estradiol—prostate cancer	8.99e-05	0.000649	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Etoposide—prostate cancer	8.96e-05	0.000647	CcSEcCtD
Raltitrexed—Ill-defined disorder—Prednisone—prostate cancer	8.93e-05	0.000644	CcSEcCtD
Raltitrexed—Thrombocytopenia—Docetaxel—prostate cancer	8.91e-05	0.000643	CcSEcCtD
Raltitrexed—Rash—Estradiol—prostate cancer	8.91e-05	0.000643	CcSEcCtD
Raltitrexed—Dermatitis—Estradiol—prostate cancer	8.9e-05	0.000643	CcSEcCtD
Raltitrexed—Anaemia—Prednisone—prostate cancer	8.89e-05	0.000642	CcSEcCtD
Raltitrexed—Headache—Estradiol—prostate cancer	8.85e-05	0.000639	CcSEcCtD
Raltitrexed—Oedema—Capecitabine—prostate cancer	8.81e-05	0.000636	CcSEcCtD
Raltitrexed—Renal failure—Doxorubicin—prostate cancer	8.76e-05	0.000632	CcSEcCtD
Raltitrexed—Infection—Capecitabine—prostate cancer	8.76e-05	0.000632	CcSEcCtD
Raltitrexed—Stomatitis—Doxorubicin—prostate cancer	8.68e-05	0.000627	CcSEcCtD
Raltitrexed—Anorexia—Docetaxel—prostate cancer	8.68e-05	0.000626	CcSEcCtD
Raltitrexed—Malaise—Prednisone—prostate cancer	8.67e-05	0.000626	CcSEcCtD
Raltitrexed—TYMS—Levonorgestrel—Ethinyl Estradiol—prostate cancer	8.67e-05	0.0228	CbGdCrCtD
Raltitrexed—Abdominal pain—Etoposide—prostate cancer	8.66e-05	0.000625	CcSEcCtD
Raltitrexed—Body temperature increased—Etoposide—prostate cancer	8.66e-05	0.000625	CcSEcCtD
Raltitrexed—Conjunctivitis—Doxorubicin—prostate cancer	8.66e-05	0.000625	CcSEcCtD
Raltitrexed—Thrombocytopenia—Capecitabine—prostate cancer	8.63e-05	0.000623	CcSEcCtD
Raltitrexed—Sweating—Doxorubicin—prostate cancer	8.54e-05	0.000616	CcSEcCtD
Raltitrexed—Hyperhidrosis—Capecitabine—prostate cancer	8.52e-05	0.000615	CcSEcCtD
Raltitrexed—Anorexia—Capecitabine—prostate cancer	8.4e-05	0.000606	CcSEcCtD
Raltitrexed—Nausea—Estradiol—prostate cancer	8.4e-05	0.000606	CcSEcCtD
Raltitrexed—Vomiting—Mitoxantrone—prostate cancer	8.37e-05	0.000604	CcSEcCtD
Raltitrexed—Rash—Mitoxantrone—prostate cancer	8.3e-05	0.000599	CcSEcCtD
Raltitrexed—Dermatitis—Mitoxantrone—prostate cancer	8.3e-05	0.000599	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Docetaxel—prostate cancer	8.29e-05	0.000599	CcSEcCtD
Raltitrexed—Headache—Mitoxantrone—prostate cancer	8.25e-05	0.000596	CcSEcCtD
Raltitrexed—Arthralgia—Prednisone—prostate cancer	8.19e-05	0.000591	CcSEcCtD
Raltitrexed—Discomfort—Prednisone—prostate cancer	8.09e-05	0.000584	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Capecitabine—prostate cancer	8.03e-05	0.00058	CcSEcCtD
Raltitrexed—Dyspepsia—Docetaxel—prostate cancer	8.01e-05	0.000578	CcSEcCtD
Raltitrexed—Decreased appetite—Docetaxel—prostate cancer	7.91e-05	0.000571	CcSEcCtD
Raltitrexed—Asthenia—Etoposide—prostate cancer	7.86e-05	0.000567	CcSEcCtD
Raltitrexed—Oedema—Prednisone—prostate cancer	7.85e-05	0.000567	CcSEcCtD
Raltitrexed—Nausea—Mitoxantrone—prostate cancer	7.82e-05	0.000565	CcSEcCtD
Raltitrexed—Infection—Prednisone—prostate cancer	7.8e-05	0.000563	CcSEcCtD
Raltitrexed—FPGS—Metabolism—CYP2A6—prostate cancer	7.79e-05	0.000985	CbGpPWpGaD
Raltitrexed—Pain—Docetaxel—prostate cancer	7.78e-05	0.000562	CcSEcCtD
Raltitrexed—Constipation—Docetaxel—prostate cancer	7.78e-05	0.000562	CcSEcCtD
Raltitrexed—TYMS—Circadian rythm related genes—LEP—prostate cancer	7.77e-05	0.000983	CbGpPWpGaD
Raltitrexed—FPGS—Disease—HSPA1A—prostate cancer	7.76e-05	0.000981	CbGpPWpGaD
Raltitrexed—Dyspepsia—Capecitabine—prostate cancer	7.76e-05	0.00056	CcSEcCtD
Raltitrexed—Pruritus—Etoposide—prostate cancer	7.75e-05	0.000559	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—ESR1—prostate cancer	7.73e-05	0.000977	CbGpPWpGaD
Raltitrexed—Arrhythmia—Epirubicin—prostate cancer	7.72e-05	0.000557	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—HIST1H4H—prostate cancer	7.68e-05	0.000972	CbGpPWpGaD
Raltitrexed—Decreased appetite—Capecitabine—prostate cancer	7.66e-05	0.000553	CcSEcCtD
Raltitrexed—Alopecia—Epirubicin—prostate cancer	7.64e-05	0.000551	CcSEcCtD
Raltitrexed—TYMS—G1/S Transition—CDKN1A—prostate cancer	7.59e-05	0.00096	CbGpPWpGaD
Raltitrexed—Hyperhidrosis—Prednisone—prostate cancer	7.59e-05	0.000548	CcSEcCtD
Raltitrexed—TYMS—Metabolism—GRHPR—prostate cancer	7.58e-05	0.000959	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—UGT2B17—prostate cancer	7.58e-05	0.000959	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CKMT2—prostate cancer	7.58e-05	0.000959	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—UGT2B15—prostate cancer	7.58e-05	0.000959	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—AKR1C3—prostate cancer	7.58e-05	0.000958	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—BAD—prostate cancer	7.54e-05	0.000954	CbGpPWpGaD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—MYC—prostate cancer	7.54e-05	0.000953	CbGpPWpGaD
Raltitrexed—Constipation—Capecitabine—prostate cancer	7.54e-05	0.000544	CcSEcCtD
Raltitrexed—Pain—Capecitabine—prostate cancer	7.54e-05	0.000544	CcSEcCtD
Raltitrexed—FPGS—Metabolism—PRKACB—prostate cancer	7.54e-05	0.000953	CbGpPWpGaD
Raltitrexed—Feeling abnormal—Docetaxel—prostate cancer	7.5e-05	0.000541	CcSEcCtD
Raltitrexed—Diarrhoea—Etoposide—prostate cancer	7.49e-05	0.000541	CcSEcCtD
Raltitrexed—Anorexia—Prednisone—prostate cancer	7.48e-05	0.00054	CcSEcCtD
Raltitrexed—FPGS—Metabolism—CYP17A1—prostate cancer	7.46e-05	0.000943	CbGpPWpGaD
Raltitrexed—FPGS—Disease—CASP9—prostate cancer	7.45e-05	0.000942	CbGpPWpGaD
Raltitrexed—Gastrointestinal pain—Docetaxel—prostate cancer	7.44e-05	0.000537	CcSEcCtD
Raltitrexed—Dysgeusia—Epirubicin—prostate cancer	7.37e-05	0.000532	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—APC—prostate cancer	7.3e-05	0.000924	CbGpPWpGaD
Raltitrexed—Feeling abnormal—Capecitabine—prostate cancer	7.26e-05	0.000524	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—MAD1L1—prostate cancer	7.22e-05	0.000914	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—EGF—prostate cancer	7.22e-05	0.000913	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PRKCQ—prostate cancer	7.21e-05	0.000912	CbGpPWpGaD
Raltitrexed—Gastrointestinal pain—Capecitabine—prostate cancer	7.21e-05	0.00052	CcSEcCtD
Raltitrexed—Abdominal pain—Docetaxel—prostate cancer	7.2e-05	0.000519	CcSEcCtD
Raltitrexed—Body temperature increased—Docetaxel—prostate cancer	7.2e-05	0.000519	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Prednisone—prostate cancer	7.15e-05	0.000516	CcSEcCtD
Raltitrexed—Arrhythmia—Doxorubicin—prostate cancer	7.14e-05	0.000516	CcSEcCtD
Raltitrexed—TYMS—Metabolism—PGAM2—prostate cancer	7.13e-05	0.000902	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—SULT2B1—prostate cancer	7.13e-05	0.000902	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—RFK—prostate cancer	7.13e-05	0.000902	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—MBTPS1—prostate cancer	7.13e-05	0.000902	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—AOX1—prostate cancer	7.13e-05	0.000902	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—GSTM3—prostate cancer	7.13e-05	0.000902	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—NAGLU—prostate cancer	7.13e-05	0.000902	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—NCOA2—prostate cancer	7.11e-05	0.000899	CbGpPWpGaD
Raltitrexed—Alopecia—Doxorubicin—prostate cancer	7.07e-05	0.00051	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle, Mitotic—TOP2A—prostate cancer	7e-05	0.000886	CbGpPWpGaD
Raltitrexed—Ill-defined disorder—Epirubicin—prostate cancer	6.98e-05	0.000504	CcSEcCtD
Raltitrexed—Abdominal pain—Capecitabine—prostate cancer	6.97e-05	0.000503	CcSEcCtD
Raltitrexed—Body temperature increased—Capecitabine—prostate cancer	6.97e-05	0.000503	CcSEcCtD
Raltitrexed—Vomiting—Etoposide—prostate cancer	6.96e-05	0.000503	CcSEcCtD
Raltitrexed—Anaemia—Epirubicin—prostate cancer	6.95e-05	0.000502	CcSEcCtD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—CDKN1B—prostate cancer	6.93e-05	0.000877	CbGpPWpGaD
Raltitrexed—Dyspepsia—Prednisone—prostate cancer	6.91e-05	0.000499	CcSEcCtD
Raltitrexed—Rash—Etoposide—prostate cancer	6.91e-05	0.000499	CcSEcCtD
Raltitrexed—Dermatitis—Etoposide—prostate cancer	6.9e-05	0.000498	CcSEcCtD
Raltitrexed—Headache—Etoposide—prostate cancer	6.86e-05	0.000495	CcSEcCtD
Raltitrexed—FPGS—Disease—FGF10—prostate cancer	6.85e-05	0.000867	CbGpPWpGaD
Raltitrexed—Decreased appetite—Prednisone—prostate cancer	6.82e-05	0.000493	CcSEcCtD
Raltitrexed—Dysgeusia—Doxorubicin—prostate cancer	6.82e-05	0.000492	CcSEcCtD
Raltitrexed—Malaise—Epirubicin—prostate cancer	6.78e-05	0.00049	CcSEcCtD
Raltitrexed—FPGS—Metabolism—SLC5A5—prostate cancer	6.78e-05	0.000857	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CREBBP—prostate cancer	6.77e-05	0.000856	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—AMACR—prostate cancer	6.76e-05	0.000855	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CYP3A43—prostate cancer	6.76e-05	0.000855	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—DEGS1—prostate cancer	6.76e-05	0.000855	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—NAT1—prostate cancer	6.76e-05	0.000855	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—SRD5A2—prostate cancer	6.76e-05	0.000855	CbGpPWpGaD
Raltitrexed—Leukopenia—Epirubicin—prostate cancer	6.73e-05	0.000486	CcSEcCtD
Raltitrexed—TYMS—Circadian rythm related genes—GSK3B—prostate cancer	6.73e-05	0.000851	CbGpPWpGaD
Raltitrexed—Constipation—Prednisone—prostate cancer	6.71e-05	0.000485	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—IGF1—prostate cancer	6.69e-05	0.000846	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—AURKA—prostate cancer	6.68e-05	0.000845	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—NBN—prostate cancer	6.64e-05	0.00084	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—CYP2E1—prostate cancer	6.62e-05	0.000837	CbGpPWpGaD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—CCND1—prostate cancer	6.61e-05	0.000836	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—MLH1—prostate cancer	6.61e-05	0.000836	CbGpPWpGaD
Raltitrexed—Cough—Epirubicin—prostate cancer	6.57e-05	0.000474	CcSEcCtD
Raltitrexed—FPGS—Metabolism—NQO1—prostate cancer	6.55e-05	0.000828	CbGpPWpGaD
Raltitrexed—Asthenia—Docetaxel—prostate cancer	6.53e-05	0.000471	CcSEcCtD
Raltitrexed—FPGS—Disease—TGFBR2—prostate cancer	6.52e-05	0.000825	CbGpPWpGaD
Raltitrexed—Nausea—Etoposide—prostate cancer	6.51e-05	0.00047	CcSEcCtD
Raltitrexed—Feeling abnormal—Prednisone—prostate cancer	6.47e-05	0.000467	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—MAP2K1—prostate cancer	6.46e-05	0.000817	CbGpPWpGaD
Raltitrexed—Ill-defined disorder—Doxorubicin—prostate cancer	6.46e-05	0.000466	CcSEcCtD
Raltitrexed—FPGS—Metabolism—TH—prostate cancer	6.45e-05	0.000816	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—HSD17B1—prostate cancer	6.45e-05	0.000815	CbGpPWpGaD
Raltitrexed—Pruritus—Docetaxel—prostate cancer	6.44e-05	0.000465	CcSEcCtD
Raltitrexed—Anaemia—Doxorubicin—prostate cancer	6.43e-05	0.000464	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Prednisone—prostate cancer	6.42e-05	0.000463	CcSEcCtD
Raltitrexed—FPGS—Disease—ITPR1—prostate cancer	6.42e-05	0.000811	CbGpPWpGaD
Raltitrexed—Arthralgia—Epirubicin—prostate cancer	6.41e-05	0.000462	CcSEcCtD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—CDKN1A—prostate cancer	6.4e-05	0.000809	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—CYP3A4—prostate cancer	6.38e-05	0.000807	CbGpPWpGaD
Raltitrexed—Discomfort—Epirubicin—prostate cancer	6.33e-05	0.000457	CcSEcCtD
Raltitrexed—Asthenia—Capecitabine—prostate cancer	6.32e-05	0.000456	CcSEcCtD
Raltitrexed—TYMS—G1/S Transition—MYC—prostate cancer	6.29e-05	0.000796	CbGpPWpGaD
Raltitrexed—Malaise—Doxorubicin—prostate cancer	6.28e-05	0.000453	CcSEcCtD
Raltitrexed—FPGS—Metabolism—CYP1B1—prostate cancer	6.28e-05	0.000794	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—TOP2A—prostate cancer	6.26e-05	0.000792	CbGpPWpGaD
Raltitrexed—Pruritus—Capecitabine—prostate cancer	6.24e-05	0.00045	CcSEcCtD
Raltitrexed—Leukopenia—Doxorubicin—prostate cancer	6.23e-05	0.00045	CcSEcCtD
Raltitrexed—Diarrhoea—Docetaxel—prostate cancer	6.23e-05	0.00045	CcSEcCtD
Raltitrexed—Abdominal pain—Prednisone—prostate cancer	6.21e-05	0.000448	CcSEcCtD
Raltitrexed—Body temperature increased—Prednisone—prostate cancer	6.21e-05	0.000448	CcSEcCtD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—TP53—prostate cancer	6.19e-05	0.000783	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—FGF2—prostate cancer	6.15e-05	0.000777	CbGpPWpGaD
Raltitrexed—Oedema—Epirubicin—prostate cancer	6.14e-05	0.000443	CcSEcCtD
Raltitrexed—Infection—Epirubicin—prostate cancer	6.1e-05	0.00044	CcSEcCtD
Raltitrexed—TYMS—Circadian rythm related genes—SERPINE1—prostate cancer	6.1e-05	0.000771	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—GGT1—prostate cancer	6.08e-05	0.000769	CbGpPWpGaD
Raltitrexed—Cough—Doxorubicin—prostate cancer	6.07e-05	0.000438	CcSEcCtD
Raltitrexed—Diarrhoea—Capecitabine—prostate cancer	6.03e-05	0.000435	CcSEcCtD
Raltitrexed—Thrombocytopenia—Epirubicin—prostate cancer	6.01e-05	0.000434	CcSEcCtD
Raltitrexed—FPGS—Metabolism—NCOA1—prostate cancer	5.99e-05	0.000757	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—AURKA—prostate cancer	5.97e-05	0.000756	CbGpPWpGaD
Raltitrexed—Hyperhidrosis—Epirubicin—prostate cancer	5.94e-05	0.000428	CcSEcCtD
Raltitrexed—Arthralgia—Doxorubicin—prostate cancer	5.93e-05	0.000428	CcSEcCtD
Raltitrexed—FPGS—Metabolism—CYP19A1—prostate cancer	5.9e-05	0.000746	CbGpPWpGaD
Raltitrexed—FPGS—Disease—LPL—prostate cancer	5.88e-05	0.000744	CbGpPWpGaD
Raltitrexed—Discomfort—Doxorubicin—prostate cancer	5.86e-05	0.000423	CcSEcCtD
Raltitrexed—Anorexia—Epirubicin—prostate cancer	5.85e-05	0.000422	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—BCL2—prostate cancer	5.84e-05	0.000738	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PDGFRB—prostate cancer	5.83e-05	0.000737	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—APEX1—prostate cancer	5.8e-05	0.000734	CbGpPWpGaD
Raltitrexed—Vomiting—Docetaxel—prostate cancer	5.79e-05	0.000418	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—MDM2—prostate cancer	5.75e-05	0.000727	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—HPGD—prostate cancer	5.75e-05	0.000727	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—B4GALT4—prostate cancer	5.75e-05	0.000727	CbGpPWpGaD
Raltitrexed—Rash—Docetaxel—prostate cancer	5.74e-05	0.000414	CcSEcCtD
Raltitrexed—Dermatitis—Docetaxel—prostate cancer	5.73e-05	0.000414	CcSEcCtD
Raltitrexed—Headache—Docetaxel—prostate cancer	5.7e-05	0.000412	CcSEcCtD
Raltitrexed—FPGS—Metabolism—RXRA—prostate cancer	5.7e-05	0.00072	CbGpPWpGaD
Raltitrexed—Oedema—Doxorubicin—prostate cancer	5.68e-05	0.00041	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—ERBB2—prostate cancer	5.67e-05	0.000717	CbGpPWpGaD
Raltitrexed—Infection—Doxorubicin—prostate cancer	5.64e-05	0.000407	CcSEcCtD
Raltitrexed—FPGS—Disease—ERCC2—prostate cancer	5.63e-05	0.000712	CbGpPWpGaD
Raltitrexed—Asthenia—Prednisone—prostate cancer	5.63e-05	0.000407	CcSEcCtD
Raltitrexed—TYMS—Clobetasol propionate—Prednisone—prostate cancer	5.61e-05	0.0148	CbGdCrCtD
Raltitrexed—Vomiting—Capecitabine—prostate cancer	5.6e-05	0.000405	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CCND2—prostate cancer	5.6e-05	0.000708	CbGpPWpGaD
Raltitrexed—Musculoskeletal discomfort—Epirubicin—prostate cancer	5.59e-05	0.000404	CcSEcCtD
Raltitrexed—Thrombocytopenia—Doxorubicin—prostate cancer	5.56e-05	0.000402	CcSEcCtD
Raltitrexed—Rash—Capecitabine—prostate cancer	5.56e-05	0.000401	CcSEcCtD
Raltitrexed—Pruritus—Prednisone—prostate cancer	5.55e-05	0.000401	CcSEcCtD
Raltitrexed—Dermatitis—Capecitabine—prostate cancer	5.55e-05	0.000401	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—prostate cancer	5.54e-05	0.000701	CbGpPWpGaD
Raltitrexed—TYMS—Flunisolide—Prednisone—prostate cancer	5.54e-05	0.0146	CbGdCrCtD
Raltitrexed—Headache—Capecitabine—prostate cancer	5.52e-05	0.000399	CcSEcCtD
Raltitrexed—FPGS—Disease—ERBB3—prostate cancer	5.51e-05	0.000697	CbGpPWpGaD
Raltitrexed—FPGS—Disease—FGFR2—prostate cancer	5.5e-05	0.000696	CbGpPWpGaD
Raltitrexed—Hyperhidrosis—Doxorubicin—prostate cancer	5.49e-05	0.000396	CcSEcCtD
Raltitrexed—FPGS—Metabolism—COMT—prostate cancer	5.49e-05	0.000694	CbGpPWpGaD
Raltitrexed—TYMS—Triamcinolone—Prednisone—prostate cancer	5.48e-05	0.0144	CbGdCrCtD
Raltitrexed—FPGS—Metabolism—GSTP1—prostate cancer	5.46e-05	0.000691	CbGpPWpGaD
Raltitrexed—Anorexia—Doxorubicin—prostate cancer	5.42e-05	0.000391	CcSEcCtD
Raltitrexed—Nausea—Docetaxel—prostate cancer	5.41e-05	0.00039	CcSEcCtD
Raltitrexed—Dyspepsia—Epirubicin—prostate cancer	5.41e-05	0.00039	CcSEcCtD
Raltitrexed—TYMS—Metabolism—TNFRSF21—prostate cancer	5.4e-05	0.000683	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—ITPR1—prostate cancer	5.37e-05	0.00068	CbGpPWpGaD
Raltitrexed—Diarrhoea—Prednisone—prostate cancer	5.37e-05	0.000388	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—CHEK2—prostate cancer	5.34e-05	0.000676	CbGpPWpGaD
Raltitrexed—Decreased appetite—Epirubicin—prostate cancer	5.34e-05	0.000385	CcSEcCtD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—MYC—prostate cancer	5.3e-05	0.000671	CbGpPWpGaD
Raltitrexed—FPGS—Disease—MTHFR—prostate cancer	5.3e-05	0.00067	CbGpPWpGaD
Raltitrexed—FPGS—Disease—TERT—prostate cancer	5.28e-05	0.000668	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CYP7B1—prostate cancer	5.26e-05	0.000665	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—MTAP—prostate cancer	5.26e-05	0.000665	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1B—prostate cancer	5.25e-05	0.000664	CbGpPWpGaD
Raltitrexed—Constipation—Epirubicin—prostate cancer	5.25e-05	0.000379	CcSEcCtD
Raltitrexed—Pain—Epirubicin—prostate cancer	5.25e-05	0.000379	CcSEcCtD
Raltitrexed—Nausea—Capecitabine—prostate cancer	5.24e-05	0.000378	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—APEX1—prostate cancer	5.19e-05	0.000656	CbGpPWpGaD
Raltitrexed—Musculoskeletal discomfort—Doxorubicin—prostate cancer	5.18e-05	0.000374	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—prostate cancer	5.15e-05	0.000651	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—SRD5A1—prostate cancer	5.12e-05	0.000648	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—SULT1E1—prostate cancer	5.12e-05	0.000648	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—TYMS—prostate cancer	5.08e-05	0.000642	CbGpPWpGaD
Raltitrexed—Feeling abnormal—Epirubicin—prostate cancer	5.06e-05	0.000365	CcSEcCtD
Raltitrexed—TYMS—Diflorasone—Prednisone—prostate cancer	5.05e-05	0.0133	CbGdCrCtD
Raltitrexed—FPGS—Disease—HIF1A—prostate cancer	5.05e-05	0.000639	CbGpPWpGaD
Raltitrexed—Gastrointestinal pain—Epirubicin—prostate cancer	5.02e-05	0.000362	CcSEcCtD
Raltitrexed—FPGS—Metabolism—GSTM1—prostate cancer	5.02e-05	0.000635	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—prostate cancer	5.01e-05	0.000634	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—CCND2—prostate cancer	5.01e-05	0.000633	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—BRCA1—prostate cancer	5.01e-05	0.000633	CbGpPWpGaD
Raltitrexed—Dyspepsia—Doxorubicin—prostate cancer	5e-05	0.000361	CcSEcCtD
Raltitrexed—Vomiting—Prednisone—prostate cancer	4.99e-05	0.00036	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—prostate cancer	4.96e-05	0.000627	CbGpPWpGaD
Raltitrexed—Rash—Prednisone—prostate cancer	4.95e-05	0.000357	CcSEcCtD
Raltitrexed—Dermatitis—Prednisone—prostate cancer	4.95e-05	0.000357	CcSEcCtD
Raltitrexed—Decreased appetite—Doxorubicin—prostate cancer	4.94e-05	0.000356	CcSEcCtD
Raltitrexed—FPGS—Metabolism—LPL—prostate cancer	4.93e-05	0.000623	CbGpPWpGaD
Raltitrexed—Headache—Prednisone—prostate cancer	4.92e-05	0.000355	CcSEcCtD
Raltitrexed—TYMS—Metabolism—HSD17B3—prostate cancer	4.89e-05	0.000618	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ACSL4—prostate cancer	4.89e-05	0.000618	CbGpPWpGaD
Raltitrexed—FPGS—Disease—CAV1—prostate cancer	4.88e-05	0.000618	CbGpPWpGaD
Raltitrexed—Pain—Doxorubicin—prostate cancer	4.86e-05	0.000351	CcSEcCtD
Raltitrexed—Constipation—Doxorubicin—prostate cancer	4.86e-05	0.000351	CcSEcCtD
Raltitrexed—Abdominal pain—Epirubicin—prostate cancer	4.85e-05	0.00035	CcSEcCtD
Raltitrexed—Body temperature increased—Epirubicin—prostate cancer	4.85e-05	0.00035	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1A—prostate cancer	4.85e-05	0.000613	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—prostate cancer	4.84e-05	0.000612	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—CYP1A1—prostate cancer	4.76e-05	0.000602	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—ERCC2—prostate cancer	4.72e-05	0.000597	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—UMPS—prostate cancer	4.68e-05	0.000593	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ARG2—prostate cancer	4.68e-05	0.000593	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PHGDH—prostate cancer	4.68e-05	0.000593	CbGpPWpGaD
Raltitrexed—Feeling abnormal—Doxorubicin—prostate cancer	4.68e-05	0.000338	CcSEcCtD
Raltitrexed—Nausea—Prednisone—prostate cancer	4.66e-05	0.000337	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Doxorubicin—prostate cancer	4.65e-05	0.000335	CcSEcCtD
Raltitrexed—TYMS—Circadian rythm related genes—PTEN—prostate cancer	4.64e-05	0.000587	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—EP300—prostate cancer	4.61e-05	0.000583	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—LDHB—prostate cancer	4.59e-05	0.000581	CbGpPWpGaD
Raltitrexed—FPGS—Disease—BAD—prostate cancer	4.59e-05	0.000581	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—BRCA2—prostate cancer	4.53e-05	0.000573	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CYP3A5—prostate cancer	4.51e-05	0.00057	CbGpPWpGaD
Raltitrexed—Body temperature increased—Doxorubicin—prostate cancer	4.49e-05	0.000324	CcSEcCtD
Raltitrexed—Abdominal pain—Doxorubicin—prostate cancer	4.49e-05	0.000324	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—SRC—prostate cancer	4.48e-05	0.000567	CbGpPWpGaD
Raltitrexed—FPGS—Disease—APC—prostate cancer	4.45e-05	0.000563	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—MTHFR—prostate cancer	4.43e-05	0.000561	CbGpPWpGaD
Raltitrexed—TYMS—Budesonide—Prednisone—prostate cancer	4.43e-05	0.0117	CbGdCrCtD
Raltitrexed—TYMS—Circadian rythm related genes—EP300—prostate cancer	4.43e-05	0.00056	CbGpPWpGaD
Raltitrexed—Asthenia—Epirubicin—prostate cancer	4.41e-05	0.000318	CcSEcCtD
Raltitrexed—FPGS—Disease—EGF—prostate cancer	4.4e-05	0.000556	CbGpPWpGaD
Raltitrexed—FPGS—Disease—IRS1—prostate cancer	4.4e-05	0.000556	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—prostate cancer	4.37e-05	0.000552	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PDHA1—prostate cancer	4.36e-05	0.000551	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—TCN2—prostate cancer	4.36e-05	0.000551	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—GSTA3—prostate cancer	4.36e-05	0.000551	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—UCP3—prostate cancer	4.36e-05	0.000551	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PPARA—prostate cancer	4.35e-05	0.00055	CbGpPWpGaD
Raltitrexed—Pruritus—Epirubicin—prostate cancer	4.34e-05	0.000314	CcSEcCtD
Raltitrexed—FPGS—Disease—GSK3B—prostate cancer	4.27e-05	0.00054	CbGpPWpGaD
Raltitrexed—TYMS—Danazol—Prednisone—prostate cancer	4.25e-05	0.0112	CbGdCrCtD
Raltitrexed—FPGS—Disease—INS—prostate cancer	4.21e-05	0.000533	CbGpPWpGaD
Raltitrexed—Diarrhoea—Epirubicin—prostate cancer	4.2e-05	0.000303	CcSEcCtD
Raltitrexed—TYMS—Metabolism—HSD3B1—prostate cancer	4.15e-05	0.000525	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—SLC22A3—prostate cancer	4.15e-05	0.000525	CbGpPWpGaD
Raltitrexed—FPGS—Disease—CREBBP—prostate cancer	4.12e-05	0.000522	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—CAV1—prostate cancer	4.09e-05	0.000517	CbGpPWpGaD
Raltitrexed—Asthenia—Doxorubicin—prostate cancer	4.08e-05	0.000294	CcSEcCtD
Raltitrexed—Pruritus—Doxorubicin—prostate cancer	4.02e-05	0.00029	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	4.02e-05	0.000508	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	4.01e-05	0.000507	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—GSTA4—prostate cancer	3.98e-05	0.000504	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—TBXAS1—prostate cancer	3.98e-05	0.000504	CbGpPWpGaD
Raltitrexed—FPGS—Disease—MAP2K1—prostate cancer	3.94e-05	0.000498	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	3.93e-05	0.000497	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PIK3CD—prostate cancer	3.91e-05	0.000495	CbGpPWpGaD
Raltitrexed—Vomiting—Epirubicin—prostate cancer	3.9e-05	0.000282	CcSEcCtD
Raltitrexed—Diarrhoea—Doxorubicin—prostate cancer	3.89e-05	0.000281	CcSEcCtD
Raltitrexed—TYMS—Metabolism—GSTA2—prostate cancer	3.88e-05	0.000491	CbGpPWpGaD
Raltitrexed—Rash—Epirubicin—prostate cancer	3.87e-05	0.000279	CcSEcCtD
Raltitrexed—FPGS—Disease—SERPINE1—prostate cancer	3.87e-05	0.000489	CbGpPWpGaD
Raltitrexed—Dermatitis—Epirubicin—prostate cancer	3.87e-05	0.000279	CcSEcCtD
Raltitrexed—Headache—Epirubicin—prostate cancer	3.85e-05	0.000278	CcSEcCtD
Raltitrexed—TYMS—Metabolism—SULT1A1—prostate cancer	3.83e-05	0.000485	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ABCG5—prostate cancer	3.83e-05	0.000485	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—TERT—prostate cancer	3.75e-05	0.000475	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—GSTA1—prostate cancer	3.75e-05	0.000474	CbGpPWpGaD
Raltitrexed—FPGS—Disease—FGF2—prostate cancer	3.74e-05	0.000474	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PIK3CG—prostate cancer	3.73e-05	0.000471	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	3.71e-05	0.00047	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—GSTO1—prostate cancer	3.7e-05	0.000468	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—NAT2—prostate cancer	3.7e-05	0.000468	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—HSD3B2—prostate cancer	3.7e-05	0.000468	CbGpPWpGaD
Raltitrexed—FPGS—Disease—NOS3—prostate cancer	3.69e-05	0.000467	CbGpPWpGaD
Raltitrexed—Nausea—Epirubicin—prostate cancer	3.65e-05	0.000263	CcSEcCtD
Raltitrexed—Vomiting—Doxorubicin—prostate cancer	3.61e-05	0.000261	CcSEcCtD
Raltitrexed—FPGS—Disease—JAK2—prostate cancer	3.59e-05	0.000454	CbGpPWpGaD
Raltitrexed—Rash—Doxorubicin—prostate cancer	3.58e-05	0.000259	CcSEcCtD
Raltitrexed—Dermatitis—Doxorubicin—prostate cancer	3.58e-05	0.000258	CcSEcCtD
Raltitrexed—Headache—Doxorubicin—prostate cancer	3.56e-05	0.000257	CcSEcCtD
Raltitrexed—TYMS—Metabolism—PLCB2—prostate cancer	3.55e-05	0.000449	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—LRP2—prostate cancer	3.55e-05	0.000449	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CYP2C18—prostate cancer	3.55e-05	0.000449	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—INS—prostate cancer	3.53e-05	0.000446	CbGpPWpGaD
Raltitrexed—FPGS—Disease—MDM2—prostate cancer	3.5e-05	0.000443	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—P4HB—prostate cancer	3.48e-05	0.00044	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—CREBBP—prostate cancer	3.45e-05	0.000437	CbGpPWpGaD
Raltitrexed—FPGS—Disease—ERBB2—prostate cancer	3.45e-05	0.000437	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	3.41e-05	0.000431	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PIK3CB—prostate cancer	3.41e-05	0.000431	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—SLC22A1—prostate cancer	3.39e-05	0.000428	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PTGS2—prostate cancer	3.38e-05	0.000427	CbGpPWpGaD
Raltitrexed—Nausea—Doxorubicin—prostate cancer	3.37e-05	0.000244	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—ATM—prostate cancer	3.37e-05	0.000427	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—SULT2A1—prostate cancer	3.3e-05	0.000417	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	3.3e-05	0.000417	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PIK3CD—prostate cancer	3.28e-05	0.000414	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—MED12—prostate cancer	3.25e-05	0.000411	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—GNG5—prostate cancer	3.22e-05	0.000407	CbGpPWpGaD
Raltitrexed—FPGS—Disease—CDKN1B—prostate cancer	3.2e-05	0.000405	CbGpPWpGaD
Raltitrexed—TYMS—Circadian rythm related genes—TP53—prostate cancer	3.17e-05	0.000401	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—NCOA3—prostate cancer	3.1e-05	0.000393	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—NOS3—prostate cancer	3.09e-05	0.000391	CbGpPWpGaD
Raltitrexed—FPGS—Disease—CTNNB1—prostate cancer	3.02e-05	0.000382	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—HPGDS—prostate cancer	2.96e-05	0.000374	CbGpPWpGaD
Raltitrexed—FPGS—Disease—CDKN1A—prostate cancer	2.95e-05	0.000373	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PTEN—prostate cancer	2.95e-05	0.000373	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CYP2C19—prostate cancer	2.94e-05	0.000372	CbGpPWpGaD
Raltitrexed—TYMS—Circadian rythm related genes—IL6—prostate cancer	2.9e-05	0.000367	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—GSTT1—prostate cancer	2.87e-05	0.000363	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ACHE—prostate cancer	2.87e-05	0.000363	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PIK3CB—prostate cancer	2.86e-05	0.000361	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CYP2A6—prostate cancer	2.84e-05	0.000359	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PTGS2—prostate cancer	2.83e-05	0.000358	CbGpPWpGaD
Raltitrexed—FPGS—Disease—EP300—prostate cancer	2.81e-05	0.000355	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	2.79e-05	0.000352	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—AKR1C3—prostate cancer	2.76e-05	0.000349	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PRKACB—prostate cancer	2.75e-05	0.000347	CbGpPWpGaD
Raltitrexed—FPGS—Disease—SRC—prostate cancer	2.73e-05	0.000346	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CYP17A1—prostate cancer	2.72e-05	0.000344	CbGpPWpGaD
Raltitrexed—FPGS—Disease—STAT3—prostate cancer	2.63e-05	0.000333	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—NCOA2—prostate cancer	2.59e-05	0.000328	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CDKN1B—prostate cancer	2.54e-05	0.000322	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—MDM2—prostate cancer	2.49e-05	0.000315	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—SLC5A5—prostate cancer	2.47e-05	0.000313	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PTEN—prostate cancer	2.47e-05	0.000312	CbGpPWpGaD
Raltitrexed—FPGS—Disease—MYC—prostate cancer	2.45e-05	0.00031	CbGpPWpGaD
Raltitrexed—FPGS—Disease—TGFB1—prostate cancer	2.44e-05	0.000309	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CCND1—prostate cancer	2.43e-05	0.000307	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CYP2E1—prostate cancer	2.41e-05	0.000305	CbGpPWpGaD
Raltitrexed—FPGS—Disease—EGFR—prostate cancer	2.39e-05	0.000303	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—NQO1—prostate cancer	2.39e-05	0.000302	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—EP300—prostate cancer	2.35e-05	0.000298	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—TH—prostate cancer	2.35e-05	0.000297	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CDKN1A—prostate cancer	2.35e-05	0.000297	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CYP3A4—prostate cancer	2.33e-05	0.000294	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CYP1B1—prostate cancer	2.29e-05	0.000289	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—CDKN1B—prostate cancer	2.27e-05	0.000288	CbGpPWpGaD
Raltitrexed—FPGS—Disease—KRAS—prostate cancer	2.26e-05	0.000286	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—EP300—prostate cancer	2.23e-05	0.000282	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—GGT1—prostate cancer	2.22e-05	0.00028	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—NCOA1—prostate cancer	2.18e-05	0.000276	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—CCND1—prostate cancer	2.17e-05	0.000274	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CYP19A1—prostate cancer	2.15e-05	0.000272	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—CDKN1A—prostate cancer	2.1e-05	0.000265	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PIK3CA—prostate cancer	2.08e-05	0.000263	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—RXRA—prostate cancer	2.08e-05	0.000263	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—COMT—prostate cancer	2e-05	0.000253	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—EP300—prostate cancer	2e-05	0.000252	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—GSTP1—prostate cancer	1.99e-05	0.000252	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ITPR1—prostate cancer	1.96e-05	0.000248	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—MYC—prostate cancer	1.95e-05	0.000246	CbGpPWpGaD
Raltitrexed—FPGS—Disease—IL6—prostate cancer	1.84e-05	0.000233	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—GSTM1—prostate cancer	1.83e-05	0.000231	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—LPL—prostate cancer	1.8e-05	0.000227	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PIK3CA—prostate cancer	1.74e-05	0.00022	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—MYC—prostate cancer	1.74e-05	0.00022	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CYP1A1—prostate cancer	1.73e-05	0.000219	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ERCC2—prostate cancer	1.72e-05	0.000217	CbGpPWpGaD
Raltitrexed—FPGS—Disease—AKT1—prostate cancer	1.7e-05	0.000215	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—MTHFR—prostate cancer	1.62e-05	0.000204	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PPARA—prostate cancer	1.59e-05	0.000201	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CAV1—prostate cancer	1.49e-05	0.000189	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—TP53—prostate cancer	1.43e-05	0.000181	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—AKT1—prostate cancer	1.42e-05	0.00018	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PIK3CG—prostate cancer	1.36e-05	0.000172	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—INS—prostate cancer	1.29e-05	0.000163	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CREBBP—prostate cancer	1.26e-05	0.000159	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PIK3CD—prostate cancer	1.19e-05	0.000151	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—NOS3—prostate cancer	1.13e-05	0.000143	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PIK3CB—prostate cancer	1.04e-05	0.000132	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PTGS2—prostate cancer	1.03e-05	0.00013	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PTEN—prostate cancer	8.99e-06	0.000114	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—EP300—prostate cancer	8.58e-06	0.000108	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PIK3CA—prostate cancer	6.34e-06	8.02e-05	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—AKT1—prostate cancer	5.18e-06	6.55e-05	CbGpPWpGaD
